Moleculin Biotech, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €25.02K
    Gross profit
    -€25.02K
    SG&A expenses
    €7.67M
    R&D expenses
    €14.17M
    EBITDA
    -€23.50M
    D&A
    €106.10K
    EBIT
    -€21.95M
    Interest expenses
    €0.00
    EBT
    -€22.90M
    Tax expenses
    €0.00
    Net income
    -€22.90M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €408.87K
    Changes in working capital
    €2.06M
    Operating cash flow
    -€18.41M
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €15.59M
    Debt repayment
    €0.00
    Other financing cash flow
    €4.68M
    Net financing cash flow
    €15.60M
    Foreign exchange effects
    -€24.15K
    Net change in cash
    -€2.84M
    Cash at end of period
    €6.52M
    Free cash flow
    -€18.41M

    Balance sheet

    Cash and cash equivalents
    €6.52M
    Cash and short-term investments
    €6.52M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €1.31M
    Total current assets
    €7.83M
    Property, plant & equipment
    €319.16K
    Goodwill
    €0.00
    Intangible assets
    €9.62M
    Long-term investments
    €0.00
    Other non-current assets
    €861.73K
    Total non-current assets
    €10.80M
    Total assets
    €18.63M
    Accounts payable
    €3.21M
    Short-term debt
    €0.00
    Other current liabilities
    €3.62M
    Total current liabilities
    €6.83M
    Long-term debt
    €251.88K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €17.73M
    Total non-current liabilities
    €17.98M
    Total liabilities
    €24.81M
    Common stock
    €25.88K
    Retained earnings
    -€144.43M
    Other equity
    -€32.78K
    Total equity
    -€6.18M
    Total liabilities and shareholders' equity
    €18.63M

    Company information

    Market capitalization
    €3.76M
    Employees
    17
    Enterprise Value
    €2.35M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    370.6% Much better than peer group: -616.0%
    ROA
    -123.0% Much better than peer group: -1,350.5%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -489.3%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.35M

    Notifications